NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹41 Cr | ₹20 Cr | ₹50 Cr | ₹57 Cr | ₹811,693 Cr |
What is the latest Consolidated Net Profit of NGL FINECHEM ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹41 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹50 Cr |
| Mar2022 | ₹57 Cr |
| Mar2021 | ₹811,693 Cr |
How is Consolidated Net Profit of NGL FINECHEM Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹41 Cr | 101.67 | |
| Mar2024 | ₹20 Cr | -59.05 | |
| Mar2023 | ₹50 Cr | -11.91 | |
| Mar2022 | ₹57 Cr | -99.99 | |
| Mar2021 | ₹811,693 Cr | - | |
Compare Consolidated Net Profit of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹811.8 Cr | -4.8% | -5.5% | -31.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,982.0 Cr | -2.9% | -1.8% | -2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,878.0 Cr | 2.1% | 0.2% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,095.0 Cr | 0.5% | 2.2% | 11.2% | Stock Analytics | |
| CIPLA | ₹122,175.0 Cr | 0.7% | -0.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,154.0 Cr | -0.1% | 2.5% | 2.5% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -4.8% |
-5.5% |
-31.8% |
| SENSEX | 0.4% |
-0.1% |
6.1% |
You may also like the below Video Courses